 |
| Russell Brenner |
CHICAGO, IL — CA, a
Chicago-based real estate investment management company, announced the
expansion of its medical office and life sciences division with the appointment
of two industry leaders.
Jimmy Hwang has joined the
firm as executive vice president of investments, while Jesse Ostrow will
serve as senior vice president of investments.
“Since launching our medical office and life sciences division
earlier this year, CA has maintained a bullish approach to acquiring,
developing and operating best-in-class healthcare, lab and research facilities
in markets across the U.S.,” said Russell Brenner, president of the
division.
“The COVID-19 pandemic highlighted the dearth of
quality medical and life sciences real estate nationally, which only
strengthened our commitment to these burgeoning sectors.
 |
| Jimmy Hwang |
"Through strategic hires like Jimmy and
Jesse, CA is positioned to quickly scale its portfolio by leveraging
longstanding relationships with capital partners, expanding the platform’s deal
sourcing network and creating further synergies with our existing verticals.
"My team and I have been focused on the
medical sector for over a decade and have watched it transform from a niche
vertical with less than $10 billion in annual transaction volume to its status
today as a highly desirable and growing asset class.”
As executive vice president of investments, Hwang is responsible
for investment management activities across the medical office and life
sciences division, as well as CA’s industrial and residential verticals. Prior
to joining the company, Hwang served as a director in the equity advisory team
at Jones Lang LaSalle.
Before JLL, Hwang was a vice president at
Evercore Partners in the real estate private capital advisory group.
 |
| Jesse Ostrow |
Hwang holds a Bachelor of Science in finance from the University
of Southern California’s Marshall School of Business and MBA from Harvard
Business School.
Ostrow, the newly appointed senior vice president of CA’s medical
office and life sciences division, is responsible for defining and implementing
the vertical’s investment activities and overseeing acquisition, financing and
sale transactions.
Before coming to CA, he was chief
investment officer at MedProperties Group, a medical real estate
investment, development and operating platform.
A graduate of the University of Michigan’s Stephen M. Ross School
of Business, where he earned a bachelor's degree in business
administration with high distinction, Ostrow also holds an MBA from the
University of Chicago’s Booth School of Business.
CA launched its medical office and life sciences division in early
2020 and is targeting $500 million of investments per year through development
and value-add acquisitions across the U.S.
CONTACTS:
Abe Tekippe, atekippe@taylorjohnson.com, (312) 267-4528
